Korean ADNI (K-ADNI) is working to comply with international standards of world-wide ADNI for development of new drugs for Alzheimer's Disease dementia patients; to evaluate the effects of vascular risk factors on Alzheimer's disease progression and Subcortical Vascular Dementia (SVaD), which comprises relatively large proportion of Asian dementia patients; and to establish the efficacy approval system for new dementia drugs. They are recruiting and collecting data comparable to that gathered through other WW-ADNI centers and data collected throughout this study are available to the research community.
Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
Research sites with ADNI protocols
